Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Invested Capital (2016 - 2020)

Historic Return on Invested Capital for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to 0.08%.

  • Avadel Pharmaceuticals' Return on Invested Capital rose 3200.0% to 0.08% in Q4 2020 from the same period last year, while for Dec 2020 it was 0.08%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.01% for FY2020, which is 2200.0% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.08% for Q4 2020, which was up 3200.0% from 0.04% recorded in Q3 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Return on Invested Capital peaked at 6.16% during Q3 2017, and registered a low of 2.45% during Q3 2016.
  • Over the past 5 years, Avadel Pharmaceuticals' median Return on Invested Capital value was 0.24% (recorded in 2018), while the average stood at 0.1%.
  • In the last 5 years, Avadel Pharmaceuticals' Return on Invested Capital surged by 86100bps in 2017 and then crashed by -64000bps in 2018.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Return on Invested Capital stood at 0.75% in 2016, then surged by 289bps to 1.41% in 2017, then tumbled by -142bps to 0.59% in 2018, then surged by 59bps to 0.24% in 2019, then surged by 133bps to 0.08% in 2020.
  • Its Return on Invested Capital was 0.08% in Q4 2020, compared to 0.04% in Q3 2020 and 0.1% in Q2 2020.